Treatment of severe postRYGB hyperinsulinemic hypoglycemia with pasireotide: A comparison with octreotide on insulin, glucagon, and GLP-1

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Surgery for obesity and related diseases 2014-05, Vol.10 (3), p.e31-e33
Hauptverfasser:	de Heide, Loek J.M., M.D, Laskewitz, Anke J., Ph.D, Apers, Jan A., M.D
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Glucose - metabolism Dose-Response Relationship, Drug Drug Therapy, Combination Female Follow-Up Studies Gastroenterology and Hepatology Gastrointestinal Agents - administration & dosage GLP-1 Glucagon Glucagon - administration & dosage Glucagon-Like Peptide 1 - administration & dosage Humans Hyperglycemia - blood Hyperglycemia - drug therapy Hyperglycemia - etiology Hyperinsulinemic hypoglycemia Hyperinsulinism - blood Hyperinsulinism - drug therapy Hyperinsulinism - etiology Hypoglycemic Agents - administration & dosage Incretins - administration & dosage Insulin - administration & dosage Insulin - blood Middle Aged Obesity, Morbid - blood Obesity, Morbid - surgery Octreotide Octreotide - administration & dosage Pasireotide Roux-en-Y gastric bypass Severity of Illness Index Surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!